Akari closes final tranche of August 2025 notes offering for $250K purchase price

Akari Therapeutics Plc

Aggregate purchase price of $3 million for notes with 20% original issuance discount.
Total principal amount issued approximately $3.8 million across all tranches.
Final tranche: $312,500 principal issued for $250,000 purchase price.
Notes are unsecured promissory notes issued under note purchase agreements dated August 1, 2025.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.